HealthEquity revenue reaches $351m as HSA growth and AI efficiencies lift margins

HealthEquity Inc. delivered record fiscal second-quarter profitability as revenue increased 8% year over year to $350.7 million, net income rose 10% to $65.6 million and adjusted EBITDA climbed 11% to $167 million. The company ended July with a record 10.7 million health savings accounts and $37.9 billion of HSA assets, while its adjusted EBITDA margin expanded to an all-time high of 48%. Management responded by raising fiscal 2027 revenue, earnings and adjusted EBITDA guidance while continuing an aggressive share-repurchase program that returned $108.1 million during Q2. The results nevertheless triggered a sharp initial share-price decline, with HQY falling as much as 13.6% in premarket trading despite beating Wall Street expectations, highlighting investor concern over the durability of custodial yields, valuation and the pace of future growth.

Non-GAAP earnings reached $1.24 per diluted share compared with approximately $1.19 expected by analysts, while revenue modestly exceeded the roughly $349.2 million consensus. The beat itself was therefore relatively small on revenue, but underlying profitability was considerably stronger, with gross profit reaching a record $258 million and representing approximately 74% of revenue compared with 71% a year earlier.

HealthEquity’s business sits at the intersection of employee benefits, healthcare spending, asset custody and financial services. That creates an unusual earnings model in which growth depends not only on the number of HSA members but also on how much money those members save, invest and spend, as well as the yield HealthEquity earns on billions of dollars of custodial cash.

HSA assets rise 14% to nearly $38 billion as account growth broadens HealthEquity’s revenue base

HealthEquity ended July with 10.7 million HSAs, up 8% from the prior-year period, while new HSAs generated through sales increased 24% to approximately 202,000. Total accounts across HSAs and complementary consumer-directed benefits reached 17.8 million, giving the platform considerably more relationships through which it can generate recurring service, custodial and payment revenue.

Total HSA assets increased 14% to $37.9 billion. Approximately $17.4 billion was held in HSA cash, while another $20.6 billion was invested, meaning invested assets now exceed cash balances and are becoming an increasingly important part of the platform’s economics.

The number of HSAs with investments increased 20% to approximately 900,000. That growth matters because members who invest their HSA balances typically have deeper relationships with the platform than users who primarily treat the accounts as short-term spending vehicles.

HealthEquity is increasingly attempting to encourage that deeper engagement. Management has launched an Investor Answers tool designed to provide personalized investing guidance and is developing a next-generation mobile application that integrates account management, investments, healthcare spending and other financial decisions more closely.

This strategy broadens the opportunity beyond simply adding new employer clients. Increasing investment adoption, Marketplace usage and spending among existing members can generate incremental revenue even if overall HSA account growth eventually slows.

The underlying HSA market also continues to benefit from rising healthcare costs and the growing use of high-deductible health plans. HSAs allow eligible consumers to make tax-advantaged contributions for future healthcare expenses, creating a long-duration asset pool that can remain on HealthEquity’s platform for many years.

That longevity helps explain why asset growth is running faster than account growth. HSAs increased 8%, but assets rose 14%, suggesting existing members are accumulating more money and investment value in addition to the company adding new accounts.

Custodial revenue reaches record $176 million as interest rates remain a powerful earnings driver

Custodial revenue increased 10% to a record $175.9 million and represented roughly half of quarterly revenue. HealthEquity generates much of this income by placing HSA cash with partner financial institutions and receiving an agreed yield, making interest rates and deposit-contract pricing major variables in the company’s earnings model.

Annualized yield on HSA cash reached approximately 3.83% during Q2. Management now expects the average fiscal 2027 yield to range between 3.85% and 3.90%, supported by contract repricing and an extensive forward-hedging program.

HealthEquity had approximately $2.3 billion of remaining HSA cash scheduled to reprice during fiscal 2027. The company also finished Q2 with about $3 billion of outstanding Treasury forward contracts that effectively lock a roughly 3.9% five-year Treasury rate, net of costs, across fiscal years 2027 through 2029.

Those hedges reduce near-term volatility in custodial economics. Rather than allowing all maturing deposits to be exposed to whatever interest rates prevail at the time, HealthEquity has locked portions of future pricing to create greater visibility.

The strategy does not eliminate rate sensitivity. Current five-year Treasury yields were above HealthEquity’s average locked forward rate at the time of the earnings call, meaning hedging can sometimes prevent the company from capturing all of the upside available in a rising-rate environment.

The tradeoff is stability. If rates decline sharply, the forward contracts can protect revenue that would otherwise reset lower, helping HealthEquity maintain more predictable earnings and giving management greater confidence when setting multi-year financial plans.

Custodial revenue therefore remains both a competitive advantage and a source of investor concern. The $17.4 billion HSA cash base creates substantial earnings power, but the valuation of that earnings stream depends partly on assumptions about future interest rates rather than account growth alone.

Record 48% EBITDA margin shows AI and operating scale are converting revenue into profit faster

Adjusted EBITDA increased 11% to a record $167 million, while adjusted EBITDA margin expanded to 48% from 46% a year earlier. Gross profit also reached a record $258 million, approximately 74% of revenue compared with 71% in the prior-year quarter.

The margin expansion is particularly important because revenue increased only 8%. Earnings growing faster than sales demonstrates that HealthEquity is extracting additional profit from its existing scale rather than requiring equivalent expense growth to support every new account.

Management attributed part of that efficiency to technology and artificial intelligence. AI-supported automation has reduced service costs per account while total accounts continued growing, helping the company handle a larger member base without proportional increases in servicing expense.

HealthEquity is using technology across customer-service interactions, operational workflows and member-facing experiences. These investments can create a reinforcing financial effect because lower service costs improve margins while better digital tools can encourage members to invest, shop through Marketplace services or consolidate more healthcare activity on the platform.

Service revenue increased 6% to a record $124.4 million. Management attributed the improvement partly to account growth, higher Marketplace participation and greater engagement from members with invested HSA balances.

Interchange revenue rose 5% to $50.4 million as member spending and transaction activity increased. That revenue is generated when members use HealthEquity-related payment products for qualified healthcare spending, creating another monetization stream separate from account fees and custodial income.

The combination creates three complementary engines. Service revenue benefits from account growth and engagement, custodial revenue benefits from cash balances and yields, while interchange benefits from healthcare spending activity.

HealthEquity’s longer-term opportunity is to deepen each member relationship across all three. If members maintain larger balances, invest more assets, use Marketplace tools and process more healthcare spending through the platform, revenue per account can increase without requiring equivalent customer-acquisition costs.

Raised fiscal 2027 guidance signals confidence even as second-half investment spending increases

Management increased its fiscal 2027 revenue outlook to between $1.411 billion and $1.421 billion. The company now expects GAAP net income of $242 million to $248 million and adjusted EBITDA between $628 million and $636 million.

Non-GAAP net income is expected between $392 million and $398 million, producing non-GAAP diluted earnings of approximately $4.66 to $4.73 per share based on an estimated 84 million diluted weighted-average shares.

The higher outlook is supported by a strong first half. Revenue reached $705.4 million during the first six months of fiscal 2027, while adjusted EBITDA climbed 14% to $331.5 million and produced a 47% first-half margin.

Management is not simply allowing all of that operating leverage to flow into short-term earnings. HealthEquity plans additional investment during the second half across technology, cybersecurity, Marketplace expansion, investing tools, member engagement and its next-generation mobile application.

Those investments explain why investors may be reluctant to extrapolate the record Q2 margin indefinitely. A 48% adjusted EBITDA margin represents exceptionally strong profitability, but management is intentionally spending some incremental cash on growth initiatives that could temporarily limit further margin expansion.

The objective is to increase the economic value of each member over time. Marketplace services, investment tools and financial guidance could transform HealthEquity from an HSA administrator into a broader healthcare-finance platform, potentially increasing both revenue per customer and retention.

Execution will determine whether those investments generate attractive returns. Health benefits are complex, and consumers may not automatically adopt additional financial products simply because they already maintain an HSA on the platform.

The company plans to provide a broader strategic update at an Investor Day scheduled for April 13, 2027. By then, investors should have greater visibility into whether newer products are generating meaningful incremental revenue rather than merely improving the user experience.

$108 million Q2 buyback accelerates as HealthEquity uses cash flow to reduce its share count

HealthEquity repurchased approximately 1.2 million shares for $108.1 million during Q2 at an average price below $90. The company still had approximately $948.4 million remaining under its existing repurchase authorization at July 31.

That represents a substantial capital-return commitment relative to the company’s size. Repurchases can increase earnings per share by reducing the number of shares outstanding, particularly if management is able to buy stock below what it believes represents long-term intrinsic value.

HealthEquity generated approximately $136 million of operating cash flow during Q2 and ended the quarter with roughly $256 million of cash. Debt stood at approximately $931 million net of issuance costs, meaning management is balancing repurchases with debt management and potential strategic acquisitions.

The company said it expects to remain active in the buyback while preserving flexibility for acquisitions and potentially reducing revolver borrowings. That capital-allocation strategy becomes increasingly important as the business generates larger amounts of recurring cash.

The sharp August 27 stock reaction could also change the economics of future repurchases. HealthEquity’s shares fell as much as 13.6% to roughly $90.23 in premarket trading despite the earnings beat and raised outlook, compared with a $104.42 closing price on August 26.

The selloff appears less connected to a specific operational failure than to expectations. Revenue beat consensus by only about 0.4%, the stock had traded near a 52-week high before earnings, and investors remain sensitive to how future interest rates could affect custodial revenue.

That creates an unusual setup. HealthEquity is reporting record account assets, margins and profits while investors are simultaneously demanding evidence that those records can continue as interest rates change and second-half investment increases.

The next several quarters should clarify whether the company’s growth is becoming structurally less dependent on custodial yield. Continued HSA account growth, greater investment adoption and faster Marketplace monetization would strengthen that case, while slowing account growth or declining cash yields would leave the business more exposed to monetary-policy changes.

Key takeaways from HealthEquity’s record HSA assets, 48% margin and raised outlook

• Q2 revenue increased 8% to $350.7 million, while net income rose 10% to a record $65.6 million as the HSA platform continued scaling.
• HSA accounts reached a record 10.7 million and new-account sales increased 24%, providing continued expansion of HealthEquity’s underlying member base.
• Total HSA assets grew 14% to $37.9 billion, outpacing account growth as existing members accumulated more cash and investment assets.
• Adjusted EBITDA climbed 11% to $167 million and margin reached a record 48%, demonstrating substantial operating leverage from technology and service-cost efficiencies.
• Custodial revenue increased 10% to $175.9 million, making HSA cash yields a powerful earnings driver but also preserving meaningful exposure to future interest-rate changes.
• HealthEquity expects fiscal 2027 HSA cash yields of 3.85% to 3.90%, supported partly by $3 billion of Treasury forward contracts extending through fiscal 2029.
• Management raised fiscal 2027 revenue guidance to $1.411 billion to $1.421 billion and adjusted EBITDA guidance to $628 million to $636 million.
• HealthEquity repurchased $108.1 million of shares during Q2 and retains approximately $948 million of authorization, giving buybacks a major role in capital allocation.
• Second-half technology, Marketplace and investment-product spending could limit near-term margin expansion but may diversify future growth beyond custodial interest income.
• HQY fell sharply despite the earnings beat and raised guidance, showing investors remain focused on valuation, rate sensitivity and the durability of record profitability.